» Articles » PMID: 27758867

The Type B Flagellin of Hypervirulent Clostridium Difficile Is Modified with Novel Sulfonated Peptidylamido-glycans

Abstract

Glycosylation of flagellins is a well recognized property of many bacterial species. In this study, we describe the structural characterization of novel flagellar glycans from a number of hypervirulent strains of C. difficile We used mass spectrometry (nano-LC-MS and MS/MS analysis) to identify a number of putative glycopeptides that carried a variety of glycoform substitutions, each of which was linked through an initial N-acetylhexosamine residue to Ser or Thr. Detailed analysis of a LLDGSSTEIR glycopeptide released by tryptic digestion, which carried two variant structures, revealed that the glycopeptide contained, in addition to carbohydrate moieties, a novel structural entity. A variety of electrospray-MS strategies using Q-TOF technology were used to define this entity, including positive and negative ion collisionally activated decomposition MS/MS, which produced unique fragmentation patterns, and high resolution accurate mass measurement to allow derivation of atomic compositions, leading to the suggestion of a taurine-containing peptidylamido-glycan structure. Finally, NMR analysis of flagellin glycopeptides provided complementary information. The glycan portion of the modification was assigned as α-Fuc3N-(1→3)-α-Rha-(1→2)-α-Rha3OMe-(1→3)-β-GlcNAc-(1→)Ser, and the novel capping moiety was shown to be comprised of taurine, alanine, and glycine. This is the first report of a novel O-linked sulfonated peptidylamido-glycan moiety decorating a flagellin protein.

Citing Articles

Flagella.

Marvaud J, Bouttier S, Saunier J, Kansau I Int J Mol Sci. 2024; 25(4).

PMID: 38396876 PMC: 10889297. DOI: 10.3390/ijms25042202.


Revised Model for the Type A Glycan Biosynthetic Pathway in Strain 630Δ Based on Quantitative Proteomics of - Mutant Strains.

Claushuis B, de Ru A, Rotman S, Van Veelen P, Dawson L, Wren B ACS Infect Dis. 2023; 9(12):2665-2674.

PMID: 37965964 PMC: 10714395. DOI: 10.1021/acsinfecdis.3c00485.


Opportunities and Challenges of Bacterial Glycosylation for the Development of Novel Antibacterial Strategies.

Yakovlieva L, Fulleborn J, Walvoort M Front Microbiol. 2021; 12:745702.

PMID: 34630370 PMC: 8498110. DOI: 10.3389/fmicb.2021.745702.


What's a Biofilm?-How the Choice of the Biofilm Model Impacts the Protein Inventory of .

Brauer M, Lassek C, Hinze C, Hoyer J, Becher D, Jahn D Front Microbiol. 2021; 12:682111.

PMID: 34177868 PMC: 8225356. DOI: 10.3389/fmicb.2021.682111.


Identification of linear epitopes on the flagellar proteins of Clostridioides difficile.

Razim A, Pacyga K, Naporowski P, Martynowski D, Szuba A, Gamian A Sci Rep. 2021; 11(1):9940.

PMID: 33976336 PMC: 8113543. DOI: 10.1038/s41598-021-89488-7.


References
1.
Szymanski C, Wren B . Protein glycosylation in bacterial mucosal pathogens. Nat Rev Microbiol. 2005; 3(3):225-37. DOI: 10.1038/nrmicro1100. View

2.
Valiente E, Bouche L, Hitchen P, Faulds-Pain A, Songane M, Dawson L . Role of Glycosyltransferases Modifying Type B Flagellin of Emerging Hypervirulent Clostridium difficile Lineages and Their Impact on Motility and Biofilm Formation. J Biol Chem. 2016; 291(49):25450-25461. PMC: 5207246. DOI: 10.1074/jbc.M116.749523. View

3.
Asakura H, Churin Y, Bauer B, Boettcher J, Bartfeld S, Hashii N . Helicobacter pylori HP0518 affects flagellin glycosylation to alter bacterial motility. Mol Microbiol. 2010; 78(5):1130-44. DOI: 10.1111/j.1365-2958.2010.07393.x. View

4.
Hunt E, Morris H . Collagen cross-links. A mass-spectrometric and 1H- and 13C-nuclear-magnetic-resonance study. Biochem J. 1973; 135(4):833-43. PMC: 1165902. DOI: 10.1042/bj1350833. View

5.
Reynolds C, Emerson J, de la Riva L, Fagan R, Fairweather N . The Clostridium difficile cell wall protein CwpV is antigenically variable between strains, but exhibits conserved aggregation-promoting function. PLoS Pathog. 2011; 7(4):e1002024. PMC: 3080850. DOI: 10.1371/journal.ppat.1002024. View